A company focused on the healing power of cannabis came out with an actual patch which relieves the symptoms of fibromyalgia, as well as diabetic nerve pain.
The patches of cannabis are nothing but transdermal patches which release the “good stuff” in the skin, which later travel through the bloodstream.
The patches in cannabis also relieve neurological nerve pain which is caused by diabetes and fibromyalgia. Some experts from the company explain that controlled doses cannot harm our body or cause any side effects.
The Cannabis Science assures their clients that the patches of cannabis can heal every part of the body which is affected. Transdermal methods work better than any other solution, which includes topical, oral, intramuscular or intravenous applications.
The CEO of Cannabis Science, Mr. Raymond C. Dabney says that their product is just a tiny bit of the whole capacity that the Cannabis Science has. Mr. Raymond explains:
“There are over 10% of all Americans that are affected by fibromyalgia. A lot of them do not even know that they have it. The neuropathic nerve pain is common, and the patches from cannabis can help in the treatment of both the diseases. There is also a strong possibility that patches can even cure those health problems.“
About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to some illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related disease. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
FOLLOW US ON INSTAGRAM HERE